Edition:
United Kingdom

DelMar Pharmaceuticals Inc (DMPI.OQ)

DMPI.OQ on NASDAQ Stock Exchange Capital Market

0.46USD
8:59pm GMT
Change (% chg)

$0.05 (+11.11%)
Prev Close
$0.41
Open
$0.44
Day's High
$0.46
Day's Low
$0.41
Volume
31,475
Avg. Vol
17,939
52-wk High
$1.59
52-wk Low
$0.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Sep 0.00 -0.088
FY 2018 Jun '18 0.00 -0.105
Mar '18 0.00 -0.131
Dec 0.00 -0.143
Sep 0.00 -0.177
FY 2017 Jun '17 0.00 -0.195
Mar '17 0.00 -0.180
Dec 0.00 -0.130
Sep 0.00 -0.230
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 8.16 19.22
P/E High - Last 5 Yrs. -- 18.11 24.23
P/E Low - Last 5 Yrs. -- 4.79 11.39
Beta 0.80 1.05 1.45
Price to Sales (TTM) -- 399.28 6.07
Price to Book (MRQ) -- 17.39 2.72
Price to Tangible Book (MRQ) 15.80 20.35 2.81
Price to Cash Flow (TTM) -- 5.65 23.44
% Owned Institutions 8.07 0.57 0.69

Dividends

  Company industry sector
Dividend Yield -- 2.52 1.98
Dividend Yield - 5 Year Avg -- 3.34 2.05
Dividend 5 Year Growth Rate -- 5.60 21.46
Payout Ratio(TTM) -- 18.92 18.66

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 30.86 16.60
Sales (TTM) vs TTM 1 Yr. Ago -- 21.94 10.60
Sales - 5 Yr. Growth Rate -- 28.28 13.73
EPS (MRQ) vs Qtr. 1 Yr. Ago -74.41 115.06 36.34
EPS (TTM) vs TTM 1 Yr. Ago -61.36 -- --
EPS - 5 Yr. Growth Rate -- -4.92 10.18
Capital Spending - 5 Yr. Growth Rate -- 39.64 19.10

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.04 0.04
Current Ratio (MRQ) 2.27 20.81 1.64
LT Debt to Equity (MRQ) 0.00 36.48 33.83
Total Debt to Equity (MRQ) 0.00 42.73 73.43
Interest Coverage (TTM) -16.16 11.53 11.07

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 46.48 3.34
Gross Margin - 5 Yr. Avg. -- 46.44 3.00
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 32.20 47.98
Operating Margin (TTM) -- -1,267.53 34.58
Operating Margin - 5 Yr. Avg. -- 80.63 40.54
Pre-Tax Margin (TTM) -- -1,291.17 35.08
Pre-Tax Margin - 5 Yr. Avg. -- 81.96 41.03
Net Profit Margin (TTM) -- -1,269.30 27.79
Net Profit Margin - 5 Yr. Avg. -- 80.85 32.50
Effective Tax Rate (TTM) -- 4.61 20.98
Effective Tax Rate - 5 Yr. Avg. -- 4.02 20.78

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 95,995,307 58,352,455
Net Income/Employee (TTM) -2,234,290 117,144,983 21,041,714
Receivable Turnover (TTM) -- 17.92 13,389.22
Inventory Turnover (TTM) -- 5.01 1.33
Asset Turnover (TTM) 0.00 0.20 0.02

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -511.25 9.64 2.58
Return on Assets - 5 Yr. Avg. -- 4.46 2.79
Return on Investment (TTM) -992.44 14.04 0.45
Return on Investment - 5 Yr. Avg. -- 7.99 0.46
Return on Equity (TTM) -- 17.15 15.43
Return on Equity - 5 Yr. Avg. -- 8.15 19.80
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -77.23 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for DelMar Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 7.00%
# of Holders: 11
Total Shares Held: 1,579,477
3 Mo. Net Change: -676,733
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 1
# Reduced Positions: 1
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.